The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024.

About The Oncology Institute, Inc.

Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

InvestorsSolebury Strategic Communicationsinvestors@theoncologyinstitute.com

Oncology Institute (NASDAQ:TOIIW)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Oncology Institute 차트를 더 보려면 여기를 클릭.
Oncology Institute (NASDAQ:TOIIW)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Oncology Institute 차트를 더 보려면 여기를 클릭.